Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 6/2006

01-11-2006 | Case Report

Acute dermatomyositis with subcutaneous generalized edema

Authors: Gláucio R. Werner de Castro, Simone Appenzeller, Manoel B. Bértolo, Lílian T. L. Costallat

Published in: Clinical Rheumatology | Issue 6/2006

Login to get access

Abstract

The authors report a 40-year-old Caucasian man with relapsing muscle and skin involvement of dermatomyositis treated with high-dose corticosteroids, taken orally, and methotrexate and human gamma globulin, both administered intravenously. After 4 months of aggressive treatment, he presented with generalized edema, considered secondary to dermatomyositis. Aggressive immunosuppression did not stop disease progression. The literature concerning anasarca due to inflammatory myopathies is revised.
Literature
1.
Medsger TA, Oddis CV (1998) Inflammatory muscle disease. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, London, pp 1–14
2.
3.
Gorelik O, Almoznino-Sarafian D, Alon I et al (2001) Acute inflammatory myopathy with severe subcutaneous edema, a new variant? Report of two cases and review of the literature. Rheumatol Int 20:163–166PubMedCrossRef
4.
Lyon-Caen O, Bouche P, Chaunu MP, Duyckaerts C, Vitoux JF (1985) Acute polymyositis with spontaneously regressive subcutaneous edema. Rev Neurol (Paris) 141:749–752
5.
Nitsche A (2000) Edema de tronco y de pared abdominal en dermatomyositis. Medicina (B Aires) 48:331–332
6.
Smyth AE, Bell AL (2000) Acute oedematous dermatomyositis. Ann Rheum Dis 59:574–575CrossRef
7.
Andonopoulos AP, Gogos CA, Tzanakakis G (1993) Subcutaneous edema: an “unrecognized” feature of acute polymyositis. Rheumatol Int 13:159–161PubMedCrossRef
8.
Mroue KH, Sharana NH, Rbeiz JG, Arayssi TK (2003) A case of edematous dermatomyositis. J Rheum 30:2722–2723PubMed
9.
Mitchell JP, Dennis GJ, Rider LG (2001) Juvenile dermatomyositis with ansarca: a possible indicator of severe disease activity. J Pediatr 138:942–945PubMedCrossRef
10.
Mehndiratta S, Banerjee P (2004) Juvenile dermatomyositis presenting with anasarca. Indian Pediatr 41:752–753PubMed
11.
Karabiber H, Aslan M, Alkan A, Yakinci C (2004) A rare complication of generalized edema in juvenile dermatomyositis: a report of one case. Brain Dev 26:269–272PubMedCrossRef
12.
13.
Go RS, Call TG (2000) Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous-related thrombotic complications. Mayo Clin Proc 75(1):83–85PubMedCrossRef
Metadata
Title
Acute dermatomyositis with subcutaneous generalized edema
Authors
Gláucio R. Werner de Castro
Simone Appenzeller
Manoel B. Bértolo
Lílian T. L. Costallat
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2006
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0053-9

Other articles of this Issue 6/2006

Clinical Rheumatology 6/2006 Go to the issue

Original Article

The usefulness of power Doppler ultrasonography in differentiating primary and secondary Raynaud’s phenomenon

Original Article

Prevalence and classification of headache in patients with systemic lupus erythematosus

Review

The burden of musculoskeletal disease—a global perspective

Case Report

An elderly female who survived more than 30 years following a diagnosis of Takayasu’s arteritis, complicated by fatal intestinal amyloidosis

Original Article

Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: a nested case-control study

Brief Report

Endocrine function and dysfunction in familial Mediterranean fever
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits